Cargando…

Factors Associated with Low-Level Viraemia and Virological Failure: Results from the Austrian HIV Cohort Study

BACKGROUND: In human immunodeficiency virus treatment adequate virological suppression is warranted, nevertheless for some patients it remains a challenge. We investigated factors associated with low-level viraemia (LLV) and virological failure (VF) under combined antiretroviral therapy (cART). MATE...

Descripción completa

Detalles Bibliográficos
Autores principales: Leierer, Gisela, Grabmeier-Pfistershammer, Katharina, Steuer, Andrea, Geit, Maria, Sarcletti, Mario, Haas, Bernhard, Kanatschnig, Manfred, Rappold, Michaela, Zangerle, Robert, Ledergerber, Bruno, Taylor, Ninon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4643888/
https://www.ncbi.nlm.nih.gov/pubmed/26566025
http://dx.doi.org/10.1371/journal.pone.0142923
_version_ 1782400580223762432
author Leierer, Gisela
Grabmeier-Pfistershammer, Katharina
Steuer, Andrea
Geit, Maria
Sarcletti, Mario
Haas, Bernhard
Kanatschnig, Manfred
Rappold, Michaela
Zangerle, Robert
Ledergerber, Bruno
Taylor, Ninon
author_facet Leierer, Gisela
Grabmeier-Pfistershammer, Katharina
Steuer, Andrea
Geit, Maria
Sarcletti, Mario
Haas, Bernhard
Kanatschnig, Manfred
Rappold, Michaela
Zangerle, Robert
Ledergerber, Bruno
Taylor, Ninon
author_sort Leierer, Gisela
collection PubMed
description BACKGROUND: In human immunodeficiency virus treatment adequate virological suppression is warranted, nevertheless for some patients it remains a challenge. We investigated factors associated with low-level viraemia (LLV) and virological failure (VF) under combined antiretroviral therapy (cART). MATERIALS AND METHODS: We analysed patients receiving standard regimens between 1(st) July 2012 and 1(st) July 2013 with at least one viral load (VL) measurement below the quantification limit (BLQ) in their treatment history. After a minimum of 6 months of unmodified cART, the next single VL measurement within 6 months was analysed. VF was defined as HIV RNA levels ≥200 copies/mL and all other quantifiable measurements were classified as LLV. Factors associated with LLV and VF compared to BLQ were identified by logistic regression models. RESULTS: Of 2276 participants, 1972 (86.6%) were BLQ, 222 (9.8%) showed LLV and 82 (3.6%) had VF. A higher risk for LLV and VF was shown in patients with cART interruptions and in patients with boosted PI therapy. The risk for LLV and VF was lower in patients from centres using the Abbott compared to the Roche assay to measure VL. A higher risk for LLV but not for VF was found in patients with a higher VL before cART [for >99.999 copies/mL: aOR (95% CI): 4.19 (2.07–8.49); for 10.000–99.999 copies/mL: aOR (95% CI): 2.52 (1.23–5.19)] and shorter cART duration [for <9 months: aOR (95% CI): 2.59 (1.38–4.86)]. A higher risk for VF but not for LLV was found in younger patients [for <30 years: aOR (95% CI): 2.76 (1.03–7.35); for 30–50 years: aOR (95% CI): 2.70 (1.26–5.79)], people originating from high prevalence countries [aOR (95% CI): 2.20 (1.09–4.42)] and in male injecting drug users [aOR (95% CI): 2.72 (1.38–5.34)]. CONCLUSIONS: For both VF and LLV, factors associated with adherence play a prominent role. Furthermore, performance characteristics of the diagnostic assay used for VL quantification should also be taken into consideration.
format Online
Article
Text
id pubmed-4643888
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-46438882015-11-18 Factors Associated with Low-Level Viraemia and Virological Failure: Results from the Austrian HIV Cohort Study Leierer, Gisela Grabmeier-Pfistershammer, Katharina Steuer, Andrea Geit, Maria Sarcletti, Mario Haas, Bernhard Kanatschnig, Manfred Rappold, Michaela Zangerle, Robert Ledergerber, Bruno Taylor, Ninon PLoS One Research Article BACKGROUND: In human immunodeficiency virus treatment adequate virological suppression is warranted, nevertheless for some patients it remains a challenge. We investigated factors associated with low-level viraemia (LLV) and virological failure (VF) under combined antiretroviral therapy (cART). MATERIALS AND METHODS: We analysed patients receiving standard regimens between 1(st) July 2012 and 1(st) July 2013 with at least one viral load (VL) measurement below the quantification limit (BLQ) in their treatment history. After a minimum of 6 months of unmodified cART, the next single VL measurement within 6 months was analysed. VF was defined as HIV RNA levels ≥200 copies/mL and all other quantifiable measurements were classified as LLV. Factors associated with LLV and VF compared to BLQ were identified by logistic regression models. RESULTS: Of 2276 participants, 1972 (86.6%) were BLQ, 222 (9.8%) showed LLV and 82 (3.6%) had VF. A higher risk for LLV and VF was shown in patients with cART interruptions and in patients with boosted PI therapy. The risk for LLV and VF was lower in patients from centres using the Abbott compared to the Roche assay to measure VL. A higher risk for LLV but not for VF was found in patients with a higher VL before cART [for >99.999 copies/mL: aOR (95% CI): 4.19 (2.07–8.49); for 10.000–99.999 copies/mL: aOR (95% CI): 2.52 (1.23–5.19)] and shorter cART duration [for <9 months: aOR (95% CI): 2.59 (1.38–4.86)]. A higher risk for VF but not for LLV was found in younger patients [for <30 years: aOR (95% CI): 2.76 (1.03–7.35); for 30–50 years: aOR (95% CI): 2.70 (1.26–5.79)], people originating from high prevalence countries [aOR (95% CI): 2.20 (1.09–4.42)] and in male injecting drug users [aOR (95% CI): 2.72 (1.38–5.34)]. CONCLUSIONS: For both VF and LLV, factors associated with adherence play a prominent role. Furthermore, performance characteristics of the diagnostic assay used for VL quantification should also be taken into consideration. Public Library of Science 2015-11-13 /pmc/articles/PMC4643888/ /pubmed/26566025 http://dx.doi.org/10.1371/journal.pone.0142923 Text en © 2015 Leierer et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Leierer, Gisela
Grabmeier-Pfistershammer, Katharina
Steuer, Andrea
Geit, Maria
Sarcletti, Mario
Haas, Bernhard
Kanatschnig, Manfred
Rappold, Michaela
Zangerle, Robert
Ledergerber, Bruno
Taylor, Ninon
Factors Associated with Low-Level Viraemia and Virological Failure: Results from the Austrian HIV Cohort Study
title Factors Associated with Low-Level Viraemia and Virological Failure: Results from the Austrian HIV Cohort Study
title_full Factors Associated with Low-Level Viraemia and Virological Failure: Results from the Austrian HIV Cohort Study
title_fullStr Factors Associated with Low-Level Viraemia and Virological Failure: Results from the Austrian HIV Cohort Study
title_full_unstemmed Factors Associated with Low-Level Viraemia and Virological Failure: Results from the Austrian HIV Cohort Study
title_short Factors Associated with Low-Level Viraemia and Virological Failure: Results from the Austrian HIV Cohort Study
title_sort factors associated with low-level viraemia and virological failure: results from the austrian hiv cohort study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4643888/
https://www.ncbi.nlm.nih.gov/pubmed/26566025
http://dx.doi.org/10.1371/journal.pone.0142923
work_keys_str_mv AT leierergisela factorsassociatedwithlowlevelviraemiaandvirologicalfailureresultsfromtheaustrianhivcohortstudy
AT grabmeierpfistershammerkatharina factorsassociatedwithlowlevelviraemiaandvirologicalfailureresultsfromtheaustrianhivcohortstudy
AT steuerandrea factorsassociatedwithlowlevelviraemiaandvirologicalfailureresultsfromtheaustrianhivcohortstudy
AT geitmaria factorsassociatedwithlowlevelviraemiaandvirologicalfailureresultsfromtheaustrianhivcohortstudy
AT sarclettimario factorsassociatedwithlowlevelviraemiaandvirologicalfailureresultsfromtheaustrianhivcohortstudy
AT haasbernhard factorsassociatedwithlowlevelviraemiaandvirologicalfailureresultsfromtheaustrianhivcohortstudy
AT kanatschnigmanfred factorsassociatedwithlowlevelviraemiaandvirologicalfailureresultsfromtheaustrianhivcohortstudy
AT rappoldmichaela factorsassociatedwithlowlevelviraemiaandvirologicalfailureresultsfromtheaustrianhivcohortstudy
AT zangerlerobert factorsassociatedwithlowlevelviraemiaandvirologicalfailureresultsfromtheaustrianhivcohortstudy
AT ledergerberbruno factorsassociatedwithlowlevelviraemiaandvirologicalfailureresultsfromtheaustrianhivcohortstudy
AT taylorninon factorsassociatedwithlowlevelviraemiaandvirologicalfailureresultsfromtheaustrianhivcohortstudy
AT factorsassociatedwithlowlevelviraemiaandvirologicalfailureresultsfromtheaustrianhivcohortstudy